Evaluation of fluorodeoxyglucose positron emission tomography in the management of soft-tissue sarcomas

Journal of Bone and Joint Surgery - Series B

Volumn 80, Issue 3, 1998, Pages 441-447

  Lucas, J D ^a   O'Doherty, M J ^a   Wong, J C H ^a,c   Bingham, J B ^a   McKee, P H ^a   Fletcher, C D M ^a,b   Smith, M A ^a  

^a ST THOMAS HOSPITAL   (United Kingdom)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE F 18; GADOLINIUM PENTETATE; IOPROMIDE;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER RECURRENCE; CHILD; COMPARATIVE STUDY; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC VALUE; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LUNG METASTASIS; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SOFT TISSUE SARCOMA; THORAX;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; EVALUATION STUDIES; FALSE NEGATIVE REACTIONS; FALSE POSITIVE REACTIONS; FEMALE; FLUORODEOXYGLUCOSE F18; FOLLOW-UP STUDIES; HUMANS; LUNG NEOPLASMS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; RADIOPHARMACEUTICALS; RETROSPECTIVE STUDIES; SARCOMA; SENSITIVITY AND SPECIFICITY; SOFT TISSUE NEOPLASMS; TOMOGRAPHY, EMISSION-COMPUTED; TOMOGRAPHY, X-RAY COMPUTED; WHOLE-BODY COUNTING;

EID: 0031745180     PISSN: 0301620X     EISSN: None     Source Type: Journal    
DOI: 10.1302/0301-620X.80B3.8232     Document Type: Article

References (39)

1. European Network of Cancer Registries. EUROCIM European cancer incidence and mortality database. 2nd ed. International Network of Cancer Registries, 1995.
2. 1985 Cancer facts and figures. 1996; estimates by American Cancer Society based on data from the National Cancer Institutes' Surveillance. Epidemiology and End Results SEER Program (1977-1981).
3. Lawrence W, Donegan WL, Natarajan N, et al. Adult soft-tissue sarcomas: a pattern of care survey of the American College of Surgeons. Ann Surg 1987;205:349-59.
4. Enzinger FM, Weiss SW. Soft tissue tumors. 3rd ed. St Louis: Mosby-Year Book Inc, 1995:1-38.
5. Huth JF, Eilber FR. Patterns of metastatic spread following resection of extremity soft-tisue sarcomas and strategies for treatment. Semin Surg Oncol 1988;4:20-6.
6. Potter DA, Glenn J, Kinsella T, et al. Patterns of recurrence in patients with high-grade soft-tissue sarcomas. J Clin Oncol 1985;3: 353-66.
7. Robinson MH, Sheppard M, Moskovic E, Fischer C. Lung metastasectomy in patients with soft tissue sarcoma. Br J Radiol 1994; 67:129-35.
8. Bland KI, McCoy DM, Kinard RE, Copeland EM III. Application of magnetic resonance imaging and computerized tomography as an adjunct to the surgical management of soft tissue sarcomas. Ann Surg 1987;205:473-81.
9. Totty WG, Murphy WA, Lee JK. Soft-tissue tumours: MR imaging. Radiology 1986;160:135-41.
10. Petasnick JP, Turner DA, Charters JR, Gitelis S, Zacharias CE. Soft-tissue masses of the locomotor system: comparison of MR imaging with CT. Radiology 1986;160:125-33.
11. Reuther G, Mutschler W. Detection of local recurrent disease in musculoskeletal tumours: magnetic resonance imaging versus computed tomography. Skeletal Radiol 1990;19:85-90.
12. Pino G, Conzi GF, Murolo C, et al. Sonographic evaluation of local recurrences of soft tissue sarcomas. J Ultrasound Med 1993;12:23-6.
13. Vanel D, Lacombe MJ, Couanet D, et al. Musculoskeletal tumors follow-up with MR imaging after treatment with surgery and radiation therapy. Radiology 1987;164:243-5.
14. Kostakoglu L, Panicek DM, Divgi CR, et al. Correlation of the findings of thallium-201 chloride scans with those of other imaging modalities and histology following therapy in patients with bone and soft tissue sarcoma. Eur J Nucl Med 1995;22:1232-7.
15. Southee AE, Kaplan WD, Jochelson MS, et al. Gallium imaging in metastatic and recurrent soft-tissue sarcoma. J Nucl Med 1992; 33:1594-9.
16. Finn HA, Simon MA, Martin WB, Darakjain H. Scinitigraphy with gallium-67 citrate in staging of soft-tissue sarcoma of the extremity. J Bone Joint Surg [Am] 1987;69-A:886-91.
17. Bitran JD, Bekerman C, Golomb HM, Simon MA. Scintigraphic evaluation of sarcomata in children and adults by Ga67 citrate. Cancer 1978;42:1760-5.
18. Kirchner PT, Simon MA. The clinical value of bone and gallium scintigraphy for soft-tissue sarcomas of the extremities. J Bone Joint Surg [Am] 1984;66-A:319-27.
19. Kaufman JH, Cedermark BJ, Parthasarathy KL, Didolkar MS, Bakshi SP. The value of 67Ga scintigraphy in soft-tissue sarcoma and chondrosarcoma. Radiology 1977;123:131-4.
20. Glaspy JA, Hawkins R, Hoh CK, Phelps ME. Use of positron emission tomography in oncology. Oncology 1993;7:41-6, 49-50, discussion 50-2, 55.
21. Adler LP, Blair HF, Williams RP, et al. Grading liposarcomas with PET using [18F]FDG. J Comput Assist Tomogr 1990;14:960-2.
22. Kern KA, Brunetti A, Norton JA, et al. Metabolic imaging of human extremity musculoskeletal tumours by PET. J Nucl Med 1988;29: 181-6.
23. Nieweg OE, Pruim J, van Ginkel RJ, et al. Fluorine-18-fluorodeoxyglucose PET imaging of soft-tissue sarcoma. J Nucl Med 1996;37: 257-61.
24. Adler LP, Blair HF, Makley JT, et al. Noninvasive grading of musculoskeletal tumours using PET. J Nucl Med 1991;32:1508-12.
25. Grifteth LK, Dehdashti F, McGuire AH, et al. PET evaluation of soft tissue masses with fluorine-18 fluoro-2-deoxy-D-glucose. Radiology 1992;182:185-94.
26. Trojani M, Contesso G, Coindre JM, et al. Soft tissue sarcomas of adults; study of pathological prognostic variables and definition of a histopathological grading system. Int J Cancer 1984;33:37-42.
27. Coindre JM, Trojani M, Contesso G, et al. Reproducibility of a histopathologic grading system for adult soft tissue sarcoma. Cancer 1986;58:306-9.
28. Giuliano AE, Eilber FR, Morton DL. The management of locally recurrent soft-tissue sarcoma. Ann Surg 1982;196:87-91.
29. Suit MD, Spiro J. Role of radiation in the management of adult patients with sarcoma of soft tissue. Sem Surg Oncol 1994;10:345-56.
30. Schirren J, Krysa S, Bulzebruck H, et al. Results of surgical treatment of pulmonary metastases from soft tissue sarcomas. Recent Results Cancer Res 1995;138:123-8.
31. Vogt-Moykopf I, Bulzebruck H, Kryza S, et al. Results in surgery of pulmonary metastases. Chirurgie 1992;118:263-71.
32. Pastorino U, Valente M, Gasparini M, et al. Lung resection for metastatic sarcomas: total survival from primary treatment. J Surg Oncol 1989;40:275-80.
33. Jablons D, Steinberg SM, Roth J, et al. Metastasectomy for soft tissue sarcoma: further evidence for efficacy and prognostic indicators. J Thorac Cardiovasc Surg 1989;97:695-705.
34. Putnam JB, Roth JA, Wesley MN, Johnston MR, Rosenberg SA. Analysis of prognostic factors in patients undergoing resection of pulmonary metastases from soft tissue sarcomas. J Thorac Cardiovasc Surg 1984;87:260-8.
35. Fong Y, Coit DG, Woodruff JM, Brennan MF. Lymph node metastasis from soft tissue sarcoma in adults: analysis of data from a prospective database of 1772 sarcoma patients. Ann Surg 1993; 217:72-7.
36. Warburg O. The metabolism of tumors. New York: Richard R. Smith, Inc., 1931:129-69.
37. Wahl RL, Hutchins GD, Buchsbaum DJ, et al. 18F-2-deoxy-2-fluoro-D-glucose uptake into human tumour xenografts: feasibility studies for cancer imaging with positron-emission tomography. Cancer 1991;67:1544-50.
38. Hamberg LM, Hunter GJ, Alpert NM, et al. The dose uptake ratio as an index of gluocose metabolism: useful parameter or over simplication? J Nucl Med 1994;35:1308-12.
39. Keyes JW Jr. SUV: standard uptake or silly useless value? J Nucl Med 1995;36:1836-9.